Clinical remission in patients with severe eosinophilic asthma treated with benralizumab who were randomised to reduce their inhaled corticosteroid/formoterol dose: SHAMAL post-hoc analysis

被引：0
|
作者：
Devouassoux, Gilles [1 ,2 ,3 ]
Jackson, David J. [4 ]
Kaessner, Frank F. [5 ]
Caruso, Cristiano [6 ]
Shavit, Anat [7 ]
Olinger, Lynda [8 ,9 ]
Menzies-Gow, Andrew [7 ]
机构：
[1] Hop Croix Rousse, Serv Pneumol, Lyon, France
[2] Univ Claude Bernard Lyon 1, VIRPATH, Villeurbanne, France
[3] CRISALIS, F CRIN INSERM Network, Pavillon Ler, Toulouse, France
[4] Kings Coll London, Guys Hosp, Sch Immunol & Microbial Sci, London, England
[5] MECS GmbH, Ambulantes Zentrum Lungenkrankheiten & Schlafmed, Cottbus, Brandenburg, Germany
[6] Fdn Policlin Univ Agostino Gemelli IRCCS, UOSD DH Internal Med & Digest Dis, Rome, Italy
[7] AstraZeneca, BioPharmaceut Med Resp & Immunol, Cambridge, England
[8] Cytel Inc, Waltham, MA USA
[9] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Cambridge, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA1194
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 46 条
  • [41] EFFECT OF HIGH ICS DOSE FIXED COMBINATION EXTRAFINE BECLOMETHASONE DIPROPIONATE, FORMOTEROL FUMARATE, AND GLYCOPYRRONIUM (BDP/FF/G) PMDI ON ASTHMA CONTROL IN PATIENTS WITH PERSISTENT AIRFLOW LIMITATION (PAL): A POST-HOC ANALYSIS OF THE TRIGGER STUDY
    Singh, D.
    Virchow, J. C.
    Canonica, W. G.
    Georges, G.
    Vele, A.
    Nudo, E.
    Guller, P.
    Papi, A.
    THORAX, 2021, 76 : A19 - A20
  • [42] Influence of Different Thresholds for Asthma Control on Clinical Remission Composite Outcome in Patients Uncontrolled on ICS/LABA: A Post-hoc Analysis of Single Inhaler Triple Therapy With FF/UMEC/VI in the CAPTAIN Trial
    Oppenheimer, J.
    Pavord, I.
    Crawford, J.
    Corbridge, T.
    Howarth, P.
    Igboekwe, E.
    Moore, A.
    Noorduyn, S. G.
    Plank, M.
    Slade, D.
    Weng, S.
    Lugogo, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [43] Greater remission rates in patients with early versus long-standing disease in biologic-naive rheumatoid arthritis patients treated with abatacept: a post hoc analysis of randomised clinical trial data
    Yazici, Y.
    Reed, D. Moniz
    Klem, C.
    Rosenblatt, L.
    Wu, G.
    Kremer, J. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (03) : 494 - 499
  • [44] Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among Ulcerative Colitis patients treated with filgotinib: A post-hoc analysis from the SELECTION trial
    Schreiber, S.
    Feagan, B.
    Peyrin-Biroulet, L.
    Vermeire, S.
    Faes, M.
    Harris, K.
    Oortwijn, A.
    Daniele, P.
    Patel, H.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I007 - I008
  • [45] Post-hoc Analysis Of Short-acting Beta2-agonist Efficacy In Baseline Corticosteroid Users And Non-corticosteroid Users Following Treatment With Levalbuterol Metered-dose Inhaler, Racemic Albuterol Or Placebo In Asthma Patients Ages 4-11 Years
    Walsh, J.
    Skoner, D.
    Berger, W.
    Wilson, N.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB77 - AB77
  • [46] Repeat kidney biopsy findings of lupus nephritis patients in clinical remission treated with Mycophenolate associated with Belimumab or Mycophenolate plus standard of care therapy. A "post-hoc" analysis of participants in the BLISS-LN and open label extension study belonging to a single center
    Malvar, Ana
    Alberton, Valeria
    Recalde, Cecilia
    Heguilen, Ricardo
    LUPUS, 2023, 32 (12) : 1394 - 1401
12345